Dr Catherine Emmanuel

Level A Research Only Academic
Medicine, Westmead Clinical School
Westmead Millennium Institute for Medical Research

C24 - Westmead Hospital
The University of Sydney
NSW 2006 Australia

T: +61 2 9845 7306
E:

Publications

2014 | 2013 | 2012 | 2011 | 2010

2014

   
  • Gao, B., Russell, A., Beesley, J., Chen, X., Healey, S., Henderson, M., Wong, M., Emmanuel, C., Galletta, L., Johnatty, S., Bowtell, D., Haber, M., Norris, M., Harnett, P., Chenevix-Trench, G., Balleine, R., Defazio, A. (2014), Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer. Scientific Reports. 4, 4669. [Abstract]

2013

   
  • Emmanuel, C., Huynh, M., Matthews, J., Kelly, E., Zoellner, H. (2013), TNF-α and TGF-β synergistically stimulate elongation of human endothelial cells without transdifferentiation to smooth muscle cell phenotype. Cytokine. 61(1), 38-40. [Abstract]
  • Johnatty, S., Beesley, J., Gao, B., Chen, X., Lu, Y., Law, M., Henderson, M., Russell, A., Hedditch, E., Emmanuel, C., Fereday, S., Webb, P., Goode, E., Vierkant, R., Fridley, B., Cunningham, J., Fasching, P., Beckmann, M., Ekici, A., Hogdall, E., Kjaer, S., Jensen, A., Hogdall, C., Brown, R., Paul, J., Lambrechts, S., Despierre, E., Vergote, I., Lester, J., Karlan, B., Heitz, F., du Bois, A., Harter, P., Schwaab, I., Bean, Y., Pejovic, T., Levine, D., Goodman, M., Camey, M., Thompson, P., Lurie, G., Shildkraut, J., Berchuck, A., Terry, K., Cramer, D., Norris, M., Haber, M., MacGregor, S., deFazio, A., Chenevix-Trench, G. (2013), ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecologic Oncology. 131(1), 8-14. [Abstract]

2012

   
  • Alsop, K., Fereday, S., Meldrum, C., Defazio, A., Emmanuel, C., George, J., Dobrovic, A., Birrer, M., Webb, P., Stewart, C., Friedlander, M., Fox, S., Bowtell, D., Mitchell, G. (2012), BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group. Journal of Clinical Oncology. 30(21), 2654-2663. [Abstract]

2011

   
  • Emmanuel, C., Gava, N., Kennedy, C., Balleine, R., Sharma, R., Wain, G., Brand, A., Hogg, R., Etemadmoghadam, D., George, J., Birrer, M., Clarke, C., Chenevix-Trench, G., Bowtell, D., Harnett, P., Defazio, A. (2011), Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis. PLoS One. 6(3), e17617. [Abstract]

2010

   
  • Byrne, J., Maleki, S., Hardy, J., Gloss, B., Murali, R., Scurry, J., Fanayan, S., Emmanuel, C., Hacker, N., Sutherland, R., Defazio, A., O'Brien, P. (2010), MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome. BMC Cancer. 10, 497. [Abstract]